- Report
- December 2023
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- November 2023
- 98 Pages
Global
From €3843EUR$4,000USD£3,299GBP
- Report
- March 2024
- 187 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- December 2019
- 53 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- October 2021
- 76 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- December 2020
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- December 2020
- 298 Pages
Europe
From €5760EUR$5,995USD£4,945GBP
- Report
- December 2020
- 282 Pages
Asia Pacific
From €5760EUR$5,995USD£4,945GBP
- Report
- December 2020
- 242 Pages
North America
From €5760EUR$5,995USD£4,945GBP
- Report
- August 2020
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- October 2023
- 77 Pages
Global
From €3500EUR$3,902USD£3,110GBP
- Report
- December 2020
- 218 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5760EUR$5,995USD£4,945GBP
- Report
- September 2020
- 10 Pages
Global
From €2883EUR$3,000USD£2,474GBP
Renal denervation catheters are specialized medical devices used within the field of cardiovascular devices for the treatment of hypertension (high blood pressure) resistant to conventional drug therapy. They are employed in renal denervation, a minimally invasive procedure that aims to decrease sympathetic nerve activity by ablating renal nerves, which is believed to play a key role in the development of hypertension. The market for these devices is a niche segment within the broader cardiovascular devices sector, encompassing technologies focused on electrophysiological approaches to manage and treat cardiovascular disorders.
Cardiovascular devices comprise a wide array of products including stents, pacemakers, defibrillators, heart valves, and many others that are vital for diagnosing, preventing, managing, and treating various heart and blood vessel conditions. Renal denervation catheters distinguish themselves in this market through their specific application in hypertension management and their potential benefits in reducing cardiovascular risks associated with uncontrolled blood pressure.
Several companies participate in the renal denervation catheters market, contributing to the ongoing development of the technology and clinical practices. Prominent companies in this market include Medtronic, Boston Scientific, St. Jude Medical, and ReCor Medical. These firms are involved in designing, manufacturing, and distributing renal denervation catheters, and they frequently engage in research and development activities to enhance the efficacy and safety of their products. Show Less Read more